Malaer, Joseph D

CS1 (SLAMF7, CD319) is an effective immunotherapeutic target for multiple myeloma. [electronic resource] - American journal of cancer research 2017 - 1637-1641 p. digital

Publication Type: Journal Article; Review

2156-6976